Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer

Metastatic Breast ◽

Dose Finding ◽

Line Treatment ◽

First Line ◽

Finding Study ◽

Dose Finding Study ◽

Dose-finding study of oral idarubicin and cyclophosphamide in first-line treatment of elderly patients with metastatic breast cancer

Annals of Oncology ◽

10.1023/a:1008384820279 ◽

2000 ◽

Vol 11 (2) ◽

pp. 229-230 ◽

Cited By ~ 6

Author(s):

J.E. Kurtz ◽

G. Deplanque ◽

C. Borel ◽

C. Mathelin ◽

G. Prévost ◽

...

Keyword(s):

Breast Cancer ◽

Elderly Patients ◽

Metastatic Breast ◽

Dose Finding ◽

Line Treatment ◽

First Line ◽

Finding Study ◽

Dose Finding Study ◽

Combination of Docetaxel, Epirubicin and Vinorelbine Administered Every 2 Weeks as First-line Therapy in Patients with Metastatic Breast Cancer: A Dose-finding Study

Breast Cancer Research and Treatment ◽

10.1023/a:1024985309383 ◽

2003 ◽

Vol 80 (3) ◽

pp. 257-265 ◽

Cited By ~ 1

Author(s):

Emilio Esteban ◽

Antonio Modollel ◽

Luis González de Sande ◽

Isabel Palacio ◽

Isabel Muñiz ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Dose Finding ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Finding Study ◽

Dose Finding Study

Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-009-1021-x ◽

2009 ◽

Vol 64 (2) ◽

pp. 407-412 ◽

Cited By ~ 2

Author(s):

S. H. Waters ◽

A. Gillibrand ◽

H. Berry ◽

S. Kumar ◽

G. Velikova ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

Dose Finding ◽

Line Treatment ◽

First Line ◽

Weekly Docetaxel ◽

Finding Study ◽

Dose Finding Study ◽

Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer

Annals of Oncology ◽

10.1093/annonc/mdi308 ◽

2005 ◽

Vol 16 (10) ◽

pp. 1609-1617 ◽

Cited By ~ 4

Author(s):

O. Pagani ◽

C. Sessa ◽

F. Nolè ◽

E. Munzone ◽

D. Crivellari ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

Dose Finding ◽

Line Treatment ◽

First Line ◽

Weekly Docetaxel ◽

Finding Study ◽

Dose Finding Study ◽

A dose-finding and pharmacokinetic study of I.V. vinflunine in combination with doxorubicin as first line treatment of metastatic breast cancer.

10.1158/0008-5472.sabcs-6124 ◽

2009 ◽

Author(s):

J Machiels ◽

P Chollet ◽

A Taleb ◽

J Baurain ◽

Y Humblet ◽

...

Keyword(s):

Breast Cancer ◽

Pharmacokinetic Study ◽

Metastatic Breast ◽

Dose Finding ◽

Line Treatment ◽

First Line ◽

Dose-finding study of Docetaxel (T) and Doxorubicin (A) day 1 and 8 plus Capecitabine (X) day 1 to 14 (TAX) as first line treatment in advanced breast cancer (ABC)

European Journal of Cancer ◽

10.1016/s0959-8049(01)81203-x ◽

2001 ◽

Vol 37 ◽

pp. S194-S195 ◽

Cited By ~ 4

Author(s):

O. Pagani ◽

C. Sessa ◽

S. Longhi ◽

F. Nolè ◽

D. Crivellari ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

Dose Finding ◽

Line Treatment ◽

First Line ◽

Finding Study ◽

Dose Finding Study ◽

Faculty of 1000 evaluation for Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717976445.793471388 ◽

2013 ◽

Author(s):

Ana Maria Gonzalez-Angulo

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Open Label ◽

Phase 3 ◽

Exemestane and Chemotherapy as First-line Treatment of Metastatic Breast Cancer: Results of a Phase II Study

Clinical Breast Cancer ◽

10.3816/cbc.2010.n.041 ◽

2010 ◽

Vol 10 (4) ◽

pp. 313-317 ◽

Cited By ~ 3

Author(s):

Juan de la Haba-Rodriguez ◽

Rosario González Mancha ◽

Gumersindo Pérez Manga ◽

Enrique Aranda Aguilar ◽

José Manuel Baena Cañada ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Bevacizumab based chemotherapy in first line treatment of HER2 negative metastatic breast cancer: results of a Moroccan observational institutional study

BMC Research Notes ◽

10.1186/1756-0500-5-162 ◽

2012 ◽

Vol 5 (1) ◽

Cited By ~ 2

Author(s):

Lamiaa Boulaamane ◽

Saber Boutayeb ◽

Hassan Errihani

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

All-oral combination of vinorelbine and capecitabine as first-line treatment in HER2/Neu-negative metastatic breast cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2082-4 ◽

2013 ◽

Vol 71 (4) ◽

pp. 913-919 ◽

Cited By ~ 16

Author(s):

Hesham Tawfik ◽

Yousri Rostom ◽

Hesham Elghazaly

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽